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a  b  s  t  r  a  c  t
We  generated  a computerized  morphometric  model  to evaluate  and  quantify  the  morphological  features
in large  regenerative  nodules  (LRN),  high-grade  dysplastic  nodules  (HGDN)  and  hepatocellular  carcinoma
(HCC).
Sixteen LRN,  10  HGDN  and  16  HCC  in HCV-cirrhotic  livers  were  stained  with  H&E, smooth  muscle  actin,
CD34,  CD31  and  reticulin  to  evaluate  volume  and  surface  fractions.
On H&E  stains,  the most  discriminatory  features  between  LRN,  HGDN  and HCC  were  volume  frac-
tion  and  the  number  of hepatocyte  nuclei  in  unit  volume  and  hepatocyte  nuclear/cytoplasmic  ratio.  On
immunohistochemistry,  volume  fractions  of capillarised sinusoids,  capillary  units and  isolated  arter-
ies were  significantly  different  among  all  groups  and  highest  in  HCC;  surface  fraction  of  reticulin  was
markedly  decreased  in  HCC.
Our morphometric  model  is  an  objective  method  for quantification  of the  morphological  changes  of
the nodular  lesions,  and  it could  be  applied  to  studies  involving  histological  evaluation  of  the  spectrum
of  nodular  lesions  arising  in the  cirrhotic  liver.
© 2012 Published by Elsevier GmbH.
Introduction21
Hepatocarcinogenesis is considered a multistep process with22
accumulation of genetic and epigenetic alterations evolving from23
normal through cirrhosis and dysplastic nodules to hepatocellular24
carcinoma (HCC) [4].  Increased cell proliferation and mitotic-25
associated genes are generally involved in hepatocarcinogenesis26
[19].27
The terminology of nodular lesions in cirrhotic liver has become28
well established since the International Working Party Classifica-29
tion (IWP) in 1995 [6].  Nodules are classified as large regenerative30
nodules (LRN), as multiacinar regenerative nodules that are dis-31
tinctly larger (i.e. >5 mm)  than the background of cirrhotic nodules,32
and dysplastic nodules that are defined as nodules of hepatocytes33
with dysplasia but without definite histological criteria of malig-34
nancy; based on cellular architecture, degree of dysplasia, presence35
or absence of portal tracts and cytological features. Dysplastic nod-36
ules are subdivided into low-grade nodules that do not have any37
cytological or architectural atypia to suggest emerging HCC, and38
high-grade dysplastic nodules that show a thick cell plate and occa-39
sional pseudoglandular structures and nontriadal arteries [1,6,14].40
∗ Corresponding author at: Dept. of Morfologia Umana e Scienze Biomediche Città
Studi, Via Mangiagalli, 31, 20133 Milan, Italy. Tel.: +39 0250319662.
E-mail address: maurizio.vertemati@unimi.it (M.  Vertemati).
Tumor angiogenesis is one of the fundamental requirements 41
for tumor growth and proliferation [12]. The infiltrating inflam- 42
matory cells in tumor are closely related to tumor angiogenesis, 43
and this could be the consequence of the production of cell factors 44
and enzymes which participate in the growth and spread of tumors 45
[13]. 46
Diagnosis of focal hepatocellular lesions is still a complex issue: 47
moreover, histology-based diagnosis of HCC may  also suffer from 48
a moment of subjectivity due to inter- and intraindividual vari- 49
ations during semiquantitative analysis. Immunohistochemistry 50
has furnished a panel of markers to analyze the differences in 51
the angioarchitecture of the nodular lesions in the cirrhotic liver 52
(i.e. large regenerative nodules, dysplastic nodules and HCC): CD31 53
to detect capillary units, CD34 to evaluate capillarised sinusoids 54
and smooth muscle alpha actin (SMA) to detect unpaired arteries 55
[2,5,7].  56
Our aim was  to apply a computerized morphometric model to 57
evaluate and quantify the morphological features in LRN, high- 58
grade dysplastic nodules (HGDN) and HCC in HCV-related cirrhosis. 59
Materials and methods 60
We  studied 16 LRN (median size = 7 mm,  range 5–14 mm),  10 61
HGDN (median size = 11 mm,  range 7–18 mm), 16 HCC (median 62
size = 25 mm,  range 22–31 mm),  and 25 cirrhotic nodules (CN) 63
(median size = 3 mm,  range 2–4 mm)  surrounding the mentioned 64
0344-0338/$ – see front matter ©  2012 Published by Elsevier GmbH.
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Fig. 1. Composite of H&E-stained tissue sections (40× magnification) for each nodular lesion.
lesions were the control group. Specimens from excised liver were65
obtained from the archival files of 42 patients (32M/10F) submitted66
to liver transplantation at Niguarda Hospital Milan for HCV-related67
cirrhosis. All specimens were examined by two pathologists, and a68
consensus determination was made following the criteria and the69
nomenclature of the IWP  [6].70
HGDN showed at least moderate cytological or architectural71
atypia, increased cell density, more than 2 times higher than that72
of the adjacent liver tissue, and small-cell change (i.e. hepatocytes73
showing decreased cell volume, increased nuclear/cytoplasmic74
ratio, mild nuclear pleomorphism, giving the impression of nuclear75
crowding).76
According to our standard operating procedure for routine his-77
tological diagnosis, livers removed at transplantation are delivered78
immediately to our laboratory where they are examined and fixed79
promptly. This procedure allows proper fixation, including focal80
lesions, and reduces artifacts due to delayed fixation, which may81
affect the histological interpretation and morphometric analysis.82
The research protocol was approved by the institutional review83
boards.84
In all cases investigated, some 2-cm3 blocks were obtained85
from the excised liver, then formalin fixed soon after the receipt86
of the liver specimen and embedded in paraffin. For each case,87
5 consecutive sections (4 m)  were obtained from the selected88
block.89
Each section series was stained as follows:90
• Hematoxylin–eosin (HE) to assess volume fractions of parenchy-91
mal  and extraparencymal compartments; Fig. 1 shows one92
histological example of each type of lesion stained by HE (40×93
magnification).94
• Monoclonal antibodies against: (a) cell surface antigen CD31 to95
evaluate CD31-immunoreactive microvessels, (b) SMA  to assess96
the number of unpaired arterioles, (c) CD34 to evaluate sinusoidal97
capillarisation.98
• Silver impregnation for reticulin fibers to evaluate hepatic cell 99
plate architecture. 100
The morphometric model for liver characterization consisted of 101
many stereological variables [17,18]. 102
All morphometric variables were obtained using a computerized 103
image analyzer (Kontron-Zeiss KS400). To examine the microscopic 104
fields, two objectives, 10× and 40×, were used. 105
The stepping procedure was controlled automatically to assure 106
unbiased sampling, and more than 400 microscopic fields system- 107
atically selected were examined. 108
The observer can interactively apply techniques of enhance- 109
ment for a better definition of parenchymal and vascular structures. 110
Fields not suitable for analysis due to technical artifacts can be 111
excluded. An algorithm automatically controls the scanning stage 112
operation in order to avoid duplicate measurements of the same 113
structures. 114
Volumetric analysis was  carried out by a differential point- 115
counting procedure on different grids of points that were 116
automatically overlaid onto each microscopic field (at 40× magni- 117
fication) displayed on the monitor. A 16-points square lattice was 118
used to evaluate parenchymal and extraparenchymal components 119
(i.e. hepatocytes, sinusoids, sinusoids-like blood spaces and fibro- 120
sis) and a 144-points square lattice to evaluate hepatocyte nuclei 121
and cytoplasm, portal triads, centrilobular veins and immunohis- 122
tochemical variables (CD31, CD34 and SMA). 123
Both grids were automatically overlaid onto each microscopic 124
field displayed on the monitor. Each point was  classified as overly- 125
ing the reference structures of interest on all sections [3].  126
Surface area of reticulin was evaluated on sections at 10× mag- 127
nification by superimposing on each microscopic field a grid of four 128
lines; surface densities were calculated by differential intersection 129
counting [10]. 130
The number in unit volume was derived by diameter analysis 131
following the Schwartz–Saltykov method [15]. 132
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Fig. 2. Percentage of the different subcomponents relative to parenchymal (hep-
atocellular and sinusoids) and extraparenchymal (portal triads, fibrosis and
centrilobular veins) compartments of nodular lesions evaluated on HE stain. All
nodular lesions investigated are characterized from a severe disruption of the vas-
cular architecture, and the term centrilobular veins is referred to the central veins
involved in the fibrotic process.
During point counting procedure, an experienced operator133
blinded to the pathologist’s diagnosis or clinical history identified134
the different structures. Moreover, to assess the reproducibility of135
our morphometric model, 10 specimens were randomly selected136
from the entire pool of biopsies, reassessed as above by another137
blinded operator and compared with the initial counting.138
Statistical analysisQ3139
SPSS 17.1 software was used for statistical analysis. For each140
parameter, a comparison among different groups was performed141
by variance analysis with factorial design followed by Scheffeıˇs post142
hoc test. Furthermore, variance analysis was used to test the repro-143
ducibility of the morphometric analysis, according to the results144
obtained by two blinded operators.145
Results146
Results are shown in Tables 1–3,  and in Figs. 2–5.147
On HE-stained sections, the number of nuclei hepatocytes in148
unit volume showed the highest values in HGDN and HCCs (CN149
205,785, LRN 140,344, HGDN 374,629, HCC 394,622). Conversely,150
Fig. 3. CD31 and CD34 volume fractions in the nodular lesions (LRN, HGDN and HCC)
and  in the perilesional cirrhotic nodules (CN). For CD31 immunostaining, vessels in
the fibrous septa or in the capsule of the nodule were excluded from counting.
Fig. 4. SMA volume fraction in the nodular lesions (LRN, HGDN and HCC) and in the
perilesional cirrhotic nodules (CN).
Table 1
Main morphometric variables evaluated for the different nodular lesions (means ± standard deviations)*. p Values = probability values in ANOVA (source between pathologies).
Equal  symbols mark homogeneous subsets in Scheffè post hoc test.
Dimension CN LRN HGDN HCC p Values
Vvcit mm 3/mm3 .4472 ± .0892 .6966 ± .0343◦ .6861 ± .0475◦ .6853 ± .0595◦ <.001
Vvnuc mm3/mm3 .0274 ± .0065* .0445 ± .0072◦ .0877 ± .0126♦ .1150 ± .0051 <.001
Vvsinend mm3/mm3 .1141 ± .0397 .1581 ± .0440◦ .1672 ± .0242◦ .1633 ± .0295◦ <.001
Vvcenlo mm3/mm3 .0049 ± .0067 .0023 ± .0046 .0010 ± .0022 .0008 ± .0020 .239
Vvfib mm3/mm3 .3421 ± .0954 .1286 ± .0094◦ .1310 ± .0363◦ .1391 ± .0696◦ <.001
Vvtria mm3/mm3 .0916 ± .0444 .0145 ± .0086◦ .0147 ± .0066◦ .0078 ± .0098 <.001
N/C  – .062 ± .012* .064 ± .013* .128 ± .021◦ .169 ± .023 <.001
NV 1/ mm3 205,488 ± 114,745* 140,344 ± 55,427* 374,630 ± 87,194 394,622 ± 287,757 <.001
d¯nuc m 7.89 ± .81 7.89 ± .41 8.30 ± .68 8.83 ± .67 .516
V¯ m3 2872.75 ± 1629.43* 5839.61 ± 2574.52 1937.30 ± 558.24* 2433.55 ± 1233.52* <.001
d¯hep m 17.029 ± 3.227* 21.855 ± 3.309 15.322 ± 1.423* 16.18 ± 3.17* <.001
Volume fractions in the test area = 504 ×504 pixels occupied by hepatocyte nuclei (Vvnuc), hepatocyte cytoplasm (Vvcit), sinusoids (lumen and endothelium – Vvsinend),
fibrosis  (Vvfib), centrilobular veins (Vvcenlo), portal triads (hepatic arteries, portal veins and biliary ducts – Vvtria), number in unit volume and size distribution of hepatocyte
nuclei  (NV), mean hepatocyte diameter (d¯hep) and volume (V¯). V¯ was calculated by dividing the hepatocyte volume fraction (Vvcyt + Vvnuc) by NV; d¯hep was  then calculated
as  the diameter of a sphere of volume V¯ .
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Table 2
Morphometric variables evaluated by immunostaining for the different nodular lesions (means ± standard deviations are quoted). p Values = probability values in ANOVA
(source between pathologies). Equal symbols mark homogeneous subsets in Scheffè post hoc test.
Marker Dimension CN LRNs DN HCC p Values
CD31 mm3/mm3 .0219 ± .0060* .0258 ± .0035* .0368 ± .0025◦ .0481 ± .0105  ˆ <.001
CD34 mm3/mm3 .0149 ± .0021* .0171 ± .0012* .0267 ± .0043◦ .0436 ± .0077  ˆ <.001
SMA  mm3/mm3 .0060 ± .0006* .0067 ± .0006* .0083 ± .0005◦ .0096 ± .0014  ˆ <.001
Ret mm2/mm3 29.018 ± 7.631* 29.964 ± 1.553* 19.777 ± 2.245◦ 11.964 ± 2.394  ˆ <.001
Volume fractions occupied by CD31 immunoreactive vessels (Vvcpu), capillarised sinusoids (VvCD34), individual lesional arteries (alpha-SMA-positive arterioles) and surface
fractions occupied by reticulin (SvRet).
Table 3
Statistical analysis of inter-observer agreement on morphometric analysis: 10 randomly selected specimens are compared with initial point counting. F represents the
variance ratio related to the source of error for each evaluation by the two operators; df(1,67).
Vvcit Vvnuc Vvsinend Vvcenlo Vvfib Vvtria CD31 CD34 SMA  Ret
F 0.739 0.459 0.087 0.401 0.059 0.957 0.972 0.045 0.058 0.912
p  0.478 0.747 0.858 0.664 0.631 0.298 0.429 0.867 0.789 0.364
the mean hepatocyte volume was significantly higher in LRN. The151
nuclear/cytoplasmic ratio was highest in HCC (CN .062, LRN .064,152
HGDN .128, HCC .169). The volume fractions of centrilobular veins,153
sinusoids and fibrosis did not differ among the different nodular154
lesions. The volume fraction of portal triads was lowest in HCC,155
where they may  represent portal tracts entrapped by infiltrating156
tumor [6].157
The number of hepatocytes in unit volume (NV) showed the158
highest values in HCC and HGDN when compared to LRN and CN. It159
must be underlined that the nuclear measurements do not take into160
account distortion related to sections thickness [8].  Moreover, due161
to the overlap in values between the different categories, the inter-162
pretation of these parameters is difficult. The nuclear/cytoplasmic163
ratio was highest in HCC.164
On immunohistochemical stains (Table 2), volume fractions of165
CD31-immunoreactive microvessels (Vvcpu: CN .219, LRN .258,166
HGDN .368, HCC .481), of capillarised sinusoids (VvCD34: CN .149,167
LRN .171, HGDN .267, HCC .436) and of unpaired arterioles (SMA:168
CN .0060, LRN .0067, HGDN .0083, HCC .0096) were highest in HCC.169
Conversely, the surface fraction of reticulin was highest in LRN and170
CN, and lowest in HCC (SvRet: CN 29.02, LRN 29.9, HGDN 19.8, HCC171
11.9).172
Fig. 5. Reticuline surface fraction in the nodular lesions (LRN, HGDN and HCC) and in
the  perilesional cirrhotic nodules (CN). The symbol *37 shows that one HCC has a sur-
face fraction of reticuline well away, i.e. more than 3 times the 75–25 interquartile
distance from the rest of the tumors.
Fig. 2 shows the percentage of parenchymal (hepatocellular and 173
sinusoids) and extraparenchymal (portal triads, fibrosis and cen- 174
trilobular veins) components relative to all hepatocellular nodular 175
lesions evaluated on HE stain. 176
Figs. 3–5 show, respectively, the volume fractions referred to 177
immunohistochemical staining for each lesion investigated. 178
Table 3 shows high inter-observer agreement in assessing the 179
morphometric characteristics of the lesions. 180
Table 4 shows the average and upper or lower deviation 181
standard of some morphometric parameters that are more discrim- 182
inated among the nodular lesions. 183
Discussion 184
Hepatocellular carcinoma develops via a progressive pathway 185
from premalignant nodular lesions to HCC in the cirrhotic liver. 186
However, differentiating a premalignant lesion from HCC is often 187
difficult [6,8]. In this “technical” paper, we  used a morphometric 188
approach to evaluate and quantify the morphological features in 189
LRN, HGDN and HCC in HCV-related cirrhosis. 190
On HE stains, when considering the parenchymal compartment 191
(Table 1 and Fig. 1), the most intriguing results were related to the 192
hepatocyte compartment that showed significantly higher volume 193
fractions of hepatocyte nuclei (Vvnuc) in HCC, while the volume 194
fraction of hepatocyte cytoplasm (Vvcit) was similarly significantly 195
higher in HCC, HGDN and LRN. Of note, the number of hepatocytes 196
in unit volume (NV) showed the highest values in HCC and HGDN 197
(with the most extensive increase in HCC), where cell density is 198
Table 4
Morphometric values expressed in terms of average values and standard deviation
that  are more discriminating among nodular lesions.
Marker LRNs HGDN HCC
Vvnuc <.0512 .1003–.0651 >.1099
N/C  <.077 .149–.107 >.146
CD31 <.0293 .0393–.0343 >.0376
CD34 <.0183 .0310–.0224 >.0359
SMA <.0073 .0088–.0078 >.0082
Ret  >28.41 22.02–17.53 <14.36
The column referred to LRNs shows the values related to the average and upper
deviation standard (Vvnuc, N/C, CD31, CD34, SMA) and to the average and lower
deviation standard for reticulin evaluated by morphometry for the parameters that,
according to our data, discriminate among the different lesions investigated; in the
column referred to HGDN are shown respectively the values of the average and
upper deviation standard and of the average and lower deviation standard; in the
column of HCC are reported the values of the average and lower deviation standard.
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1.5–2 higher than in LRN. Conversely, the mean hepatocyte volume199
was highest in LRN.200
The nuclear/cytoplasmic ratio progressively increased in HGDN201
and HCC, with the highest values in HCC, while CN and LRN showed202
similar values.203
According to these results, it could be resumed that HCC and204
HGDN are characterized by increased nuclear and cellular density,205
which appear as “nuclear clouding” in histological specimens, when206
compared to LRN.207
In this context, only a morphometric evaluation can objectively208
evaluate and give evidence of such differences and assign them209
statistical significance.210
When considering immunohistochemical analysis (Table 3), the211
volume fractions occupied by CD31-immunoreactive microvessels212
and capillarised sinusoids (Fig. 3) and individual lesional arteries213
(Fig. 4) were highest in HGDN and HCC (with the most extensive214
increase in HCC) [9,11].215
Lastly, when compared to LRN, the surface fraction of reticulin216
(Fig. 5) was markedly reduced in HGDN and HCC (with the lowest217
values in HCC).218
The increased cell density with increased N/C ratio, the dif-219
ferent vascular profile (i.e. sinusoidal capillarisation and unpaired220
arteries) and the decrease/loss of reticulin in hepatocellular non-221
malignant and malignant nodules in the cirrhotic liver support the222
concept that HGDN represents a step toward neoplastic transfor-223
mation.224
Lastly, when considering CN and LRN, they showed a similar225
trend, suggesting that LRN are not dysplastic lesions.226
To evaluate the reproducibility of our morphometric model, 10227
randomly selected specimens were analyzed in a blinded fashion228
by another operator and compared with the results of the initial229
counting. As shown in Table 3, the agreement between the two230
morphometric evaluations was very high, underlying the repro-231
ducibility of our method.232
Certainly, our morphometric model introduces numerical val-233
ues and not just semiquantitative categories which, in future234
studies, could help identify subpopulations of HCC depending on235
their morphometric characteristics (as evidenced by the outlier in236
Fig. 4).237
According to our data, we identified some parameters (Table 4)238
that could help to make the correct diagnosis and that could be239
coupled to and integrated in the classical microscopic pathol-240
ogy assessment (vascular and/or capsular invasion, necrosis,241
cellular atypia, mitosis) to conceivably enhance the reliability242
and uniformity of the diagnostic evaluation of hepatic nodular243
lesions.244
Our computerized morphometric model, incorporating mea-245
sures of the extremes of the cirrhosis to HCC spectrum, also246
considering LRN and HGDN categories, is simple and lacks observer247
or subjective bias and can be used to supplement objective248
methods to achieve precise and reader-independent quantifica-249
tion of the morphological characteristics of hepatocellular nodular250
lesions.
Further studies are needed to determine the role of our mor- 251
phometric model for identifying subpopulations of HCC depending 252
on their morphometric characteristics with a prospective cohort. 253
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